Tcr2 Therapeutics Inc (the company was acquired by Adaptimmune Therapeutics plc (NASDAQ: ADAP)) (TCRR)
TCR2 Therapeutics Inc. (TCRR) Files Form 10-Q for Period Ending 2022-05-12
TCR2 Therapeutics Inc. (TCRR) Files Form 10-Q for Period Ending 2022-05-12
Company: Tcr2 Therapeutics Inc (the company was acquired by Adaptimmune Therapeutics plc (NASDAQ: ADAP)) (TCRR) Form Type: 10-Q Filing Date: 2022-05-12 Period of Report: 2022-03-31 Financial Highlights: - Assets: 323247000 - Assets: 323371000 - Liabilities: 67931000 - Liabilities: 41894000 - StockholdersEquity: 255316000